OLIVIA ROSE EMPORIUM LIMITEDActive

Company number 12444601Private limited companyIncorporated 2020

Key figures

−£26,555-1.4%
Net assets 2024/25
-30 k-20 k-10 k02020/212021/222022/232023/242024/25

Like most small UK companies, OLIVIA ROSE EMPORIUM LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand18,1052143612,1214,204
Total assets18,2051,2577722,5804,573
Total liabilities—————
Net assets / total equity-10,295-20,872-25,067-26,190-26,555
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: OLIVIA ROSE EMPORIUM LIMITED

Company

OLIVIA ROSE EMPORIUM LIMITED is a private limited company registered with Companies House under company number 12444601. It was incorporated on 5 Feb 2020. Its status is active. The registered office is in Romford (RM7). Its nature of business (SIC 2007) is retail sale of cosmetic and toilet articles in specialised stores (47750), retail sale of flowers, plants, seeds, fertilizers, pet animals and pet food in specialised stores (47760), other retail sale not in stores, stalls or markets (47990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were −£26,555, down 1.4% on the previous year. Cash at bank and in hand was £4,204. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 5 Mar 2027.